← 產業報告目錄
Crude Heparin Market Size, Share & Trends Analysis Report, By Source of Crude Heparin (Porcine Heparin, Bovine Heparin), By Application (Surgical Procedures, Cardiovascular, Orthopedic Applications, Oncology), By Formulation Type (Injectable Heparin, Non-injectable Formulations), By End-user (Hospitals, Clinics, Long-term Care Facilities), By Distribution Channel, By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-28dffbc9ff
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 9.1 Bn as of 2024, the global Crude Heparin Market is expected to climb to USD 17.8 Bn by 2034, reflecting a compound annual growth rate of 7.2% over the 2025–2034 period.
Crude Heparin encompasses an unprocessed, unrefined form of the anticoagulant medication heparin that is made from animal tissues, usually the lungs and intestines of cattle or pigs. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Crude Heparin Market Snapshot
Chapter 4. Global Crude Heparin Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Crude Heparin Market Industry Trends
4.10. Global Crude Heparin Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Crude Heparin Market Segmentation 1: By Source of Crude Heparin, Estimates & Trend Analysis
5.1. Market Share by Source of Crude Heparin, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source of Crude Heparin:
5.2.1. Porcine Heparin
5.2.1.1. Unfractionated Heparin (UFH)
5.2.1.2. Low Molecular Weight Heparin (LMWH)
5.2.1.3. Ultra-Low Molecular Weight Heparin (ULMWH)
5.2.2. Bovine Heparin
5.2.2.1. Unfractionated Heparin (UFH)
5.2.2.2. Low Molecular Weight Heparin (LMWH)
5.2.2.3. Ultra-Low Molecular Weight Heparin (ULMWH)
Chapter 6. Crude Heparin Market Segmentation 2: By Formulation Type, Estimates & Trend Analysis
6.1. Market Share by Formulation Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Formulation Type:
6.2.1. Injectable Heparin
6.2.2. Non-injectable Formulations
Chapter 7. Crude Heparin Market Segmentation 3: By End-User Industry, Estimates & Trend Analysis
7.1. Market Share by End-User Industry, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User Industry:
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Long-term Care Facilities
Chapter 8. Offline Crude Heparin Market Segmentation 4: By Distribution Channel, Estimates & Trend Analysis
8.1. Market Share by Distribution Channel, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
8.2.1. Direct Sales
8.2.2. Online Sales
8.2.3. Pharmacies
8.2.4. Wholesalers
Chapter 9. Crude Heparin Market Segmentation 5: By Application, Estimates & Trend Analysis
9.1. Market Share by Application, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
9.2.1. Surgical Procedures
9.2.2. Cardiovascular Applications
9.2.3. Orthopedic Applications
9.2.4. Oncology
Chapter 10. Crude Heparin Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Crude Heparin Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Source of Crude Heparin, 2021-2034
10.2.3. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Formulation Type, 2021-2034
10.2.4. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.2.5. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.2.6. North America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3. Europe
10.3.1. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Source of Crude Heparin, 2021-2034
10.3.3. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Formulation Type, 2021-2034
10.3.4. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.3.5. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.3.6. Europe Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Source of Crude Heparin, 2021-2034
10.4.3. Asia Pacific Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Formulation Type, 2021-2034
10.4.4. Asia Pacific Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel, 2021-2034
10.4.5. Asia Pacific Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5. Latin America
10.5.1. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Source of Crude Heparin, 2021-2034
10.5.3. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Formulation Type, 2021-2034
10.5.4. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.5.5. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.5.6. Latin America Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Source of Crude Heparin, 2021-2034
10.6.3. Middle East & Africa Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Formulation Type, 2021-2034
10.6.4. Middle East & Africa Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.6.5. Middle East & Africa Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.6.6. Middle East & Africa Crude Heparin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. DAT-Schaub
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Suanfarma
11.2.3. Hepac (Darling Ingredients)
11.2.4. Shenzhen Hepalink Pharmaceutical Group
11.2.5. Pharma Action (Tönnies Group)
11.2.6. Aspen Oss
11.2.7. Bioiberica
11.2.8. Opocrin S.p.A.
11.2.9. Celsus Laboratories
11.2.10. Fengrun Biological Technology
11.2.11. Nanjing King-friend Biochemical Pharmaceutical
11.2.12. Hebei Changshan Biochemical Pharmaceutical
11.2.13. Changzhou Qianhong Biopharma
11.2.14. Yantai Dongcheng Biochemicals
11.2.15. Huaian MDC Pharmaceutical
11.2.16. Qingdao Jiulong Biopharmaceutical
11.2.17. Shanghai Fosun Pharmaceutical
11.2.18. Sinopharm Chemical Reagent
11.2.19. Nantong Tianlong Animal By-products
11.2.20. Adeste
11.2.21. Syntex S.A.
11.2.22. Laboratorios Heber
11.2.23. Instituto Bioclon
11.2.24. Bharat Biotech
11.2.25. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們